Dah‐Shyong Yü

3.4k total citations
160 papers, 2.7k citations indexed

About

Dah‐Shyong Yü is a scholar working on Surgery, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Dah‐Shyong Yü has authored 160 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 67 papers in Surgery, 57 papers in Molecular Biology and 44 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Dah‐Shyong Yü's work include Bladder and Urothelial Cancer Treatments (32 papers), Urinary and Genital Oncology Studies (15 papers) and Urologic and reproductive health conditions (14 papers). Dah‐Shyong Yü is often cited by papers focused on Bladder and Urothelial Cancer Treatments (32 papers), Urinary and Genital Oncology Studies (15 papers) and Urologic and reproductive health conditions (14 papers). Dah‐Shyong Yü collaborates with scholars based in Taiwan, United States and Finland. Dah‐Shyong Yü's co-authors include Sun‐Yran Chang, Hossein Hosseinkhani, Po‐Da Hong, Tai‐Lung Cha, Guang‐Huan Sun, Jar‐Yi Ho, Sheng‐Tang Wu, Chia‐Lun Wu, Cheng‐Ping Yu and Dar-Shih Hsieh and has published in prestigious journals such as Chemical Reviews, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Dah‐Shyong Yü

150 papers receiving 2.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dah‐Shyong Yü Taiwan 28 1.2k 471 416 387 318 160 2.7k
Min Zhang China 32 1.5k 1.3× 476 1.0× 261 0.6× 578 1.5× 322 1.0× 209 4.1k
Nianzeng Xing China 27 1.1k 1.0× 415 0.9× 631 1.5× 489 1.3× 127 0.4× 164 3.1k
Jingjing Zhang China 33 1.4k 1.2× 259 0.5× 185 0.4× 254 0.7× 190 0.6× 194 3.3k
Peng Yang China 34 1.6k 1.4× 387 0.8× 457 1.1× 747 1.9× 155 0.5× 184 4.1k
Feng Kong China 32 1.4k 1.2× 330 0.7× 414 1.0× 374 1.0× 190 0.6× 123 2.7k
Antônio Barbieri Italy 38 1.4k 1.2× 235 0.5× 523 1.3× 951 2.5× 207 0.7× 122 3.7k
Younan Chen China 39 2.3k 1.9× 814 1.7× 291 0.7× 250 0.6× 213 0.7× 132 4.8k
Hsi‐Chin Wu Taiwan 26 664 0.6× 444 0.9× 371 0.9× 200 0.5× 291 0.9× 87 2.2k
Levent Kabasakal Türkiye 31 479 0.4× 377 0.8× 1.1k 2.7× 484 1.3× 223 0.7× 168 3.3k
Constanze Buhrmann Germany 33 1.5k 1.3× 354 0.8× 118 0.3× 555 1.4× 146 0.5× 50 3.5k

Countries citing papers authored by Dah‐Shyong Yü

Since Specialization
Citations

This map shows the geographic impact of Dah‐Shyong Yü's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dah‐Shyong Yü with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dah‐Shyong Yü more than expected).

Fields of papers citing papers by Dah‐Shyong Yü

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dah‐Shyong Yü. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dah‐Shyong Yü. The network helps show where Dah‐Shyong Yü may publish in the future.

Co-authorship network of co-authors of Dah‐Shyong Yü

This figure shows the co-authorship network connecting the top 25 collaborators of Dah‐Shyong Yü. A scholar is included among the top collaborators of Dah‐Shyong Yü based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dah‐Shyong Yü. Dah‐Shyong Yü is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yü, Dah‐Shyong, et al.. (2025). Extracellular Vesicle‐Mediated Regulation of H3C14 Contributes to Gemcitabine Resistance in Bladder Cancer. Journal of Extracellular Vesicles. 14(11). e70179–e70179.
2.
Cha, Tai‐Lung, Sheng‐Tang Wu, En Meng, et al.. (2023). Circulating Tumor Cells Predict Response of Neoadjuvant Chemotherapy in Patients with Bladder Cancer: A Preliminary Study. Diagnostics. 13(6). 1032–1032. 6 indexed citations
3.
Jhou, Hong‐Jie, Sheng‐Tang Wu, Tai‐Lung Cha, et al.. (2022). Endoscopic Combined Intrarenal Surgery Versus Percutaneous Nephrolithotomy for Complex Renal Stones: A Systematic Review and Meta-Analysis. Journal of Personalized Medicine. 12(4). 532–532. 16 indexed citations
4.
Wu, Chia‐Lun, et al.. (2022). The Study of 3D Printing-Assisted Electrospinning Technology in Producing Tissue Regeneration Polymer-Fibroin Scaffold for Ureter Repair. SHILAP Revista de lepidopterología. 48(2). 118–129. 6 indexed citations
5.
6.
7.
Wu, Chia‐Lun, Jar‐Yi Ho, Shun‐Hsing Hung, & Dah‐Shyong Yü. (2018). miR‐429 expression in bladder cancer and its correlation with tumor behavior and clinical outcome. The Kaohsiung Journal of Medical Sciences. 34(6). 335–340. 19 indexed citations
8.
Tang, Shou‐Hung, Sheng‐Tang Wu, Yu‐Chi Chen, et al.. (2015). Novel Cancer Therapeutics with Allosteric Modulation of the Mitochondrial C-Raf–DAPK Complex by Raf Inhibitor Combination Therapy. Cancer Research. 75(17). 3568–3582. 18 indexed citations
9.
Wu, Sheng‐Tang, Tai‐Lung Cha, Chih‐Wei Tsao, et al.. (2015). Management of complex urethral stricture disease: Algorithm and experience from a single institute. SHILAP Revista de lepidopterología. 26(3). 210–213. 3 indexed citations
10.
Chen, Tsung‐Chih, Dah‐Shyong Yü, Kuo-Feng Huang, et al.. (2013). Structure-based design, synthesis and biological evaluation of novel anthra[1,2-d]imidazole-6,11-dione homologues as potential antitumor agents. European Journal of Medicinal Chemistry. 69. 278–293. 23 indexed citations
11.
Yu, Cheng‐Ping, Jar‐Yi Ho, Yiting Huang, et al.. (2013). Estrogen Inhibits Renal Cell Carcinoma Cell Progression through Estrogen Receptor-β Activation. PLoS ONE. 8(2). e56667–e56667. 96 indexed citations
12.
Cha, Tai‐Lung, Shou‐Hung Tang, Sheng‐Tang Wu, et al.. (2013). Emodin modulates epigenetic modifications and suppresses bladder carcinoma cell growth. Molecular Carcinogenesis. 54(3). 167–177. 35 indexed citations
13.
Yü, Dah‐Shyong, et al.. (2013). The HDAC Inhibitor LBH589 Induces ERK-Dependent Prometaphase Arrest in Prostate Cancer via HDAC6 Inactivation and Down-Regulation. PLoS ONE. 8(9). e73401–e73401. 40 indexed citations
14.
Chen, Ying‐Hsin, Chao‐Yuan Chang, Yun‐Hsin Wang, et al.. (2011). Embryonic exposure to diclofenac disturbs actin organization and leads to myofibril misalignment. Birth Defects Research Part B Developmental and Reproductive Toxicology. 92(2). 139–147. 11 indexed citations
15.
Lin, Chih‐Yuan, et al.. (2006). Early Experience of Robotic-Assisted Coronary Artery Bypass Grafting. Zhōnghuá mínguó xīnzàngxué huì zázhì. 22(3). 154–158. 2 indexed citations
16.
Sun, Guang‐Huan, et al.. (2005). Giant Spermatocele with Multilocular Appearance: A Case Report and Literature Review. 16(2). 81–84. 2 indexed citations
17.
Meng, En, Sheng‐Tang Wu, Shang‐Sen Lee, et al.. (2000). Fistula Involving Urinary Bladder: Experience with the Management of 23 Cases. 12(3). 121–125. 2 indexed citations
18.
Juan, Chun‐Jung, et al.. (2000). Primary Renal Angiosarcoma: A Case Report. 25(2). 87–90. 2 indexed citations
19.
Yü, Dah‐Shyong, et al.. (1992). Incidental Renal Cell Carcinoma. 3(1). 678–681.
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Min Zhang Breakdown of academic impact, for papers by Nianzeng Xing Breakdown of academic impact, for papers by Jingjing Zhang Breakdown of academic impact, for papers by Peng Yang Breakdown of academic impact, for papers by Feng Kong Breakdown of academic impact, for papers by Antônio Barbieri Breakdown of academic impact, for papers by Younan Chen Breakdown of academic impact, for papers by Hsi‐Chin Wu Breakdown of academic impact, for papers by Levent Kabasakal Breakdown of academic impact, for papers by Constanze Buhrmann
Rankless by CCL
2026